BagnatoFSatiPHemondCC, et al. Imaging chronic active lesions in multiple sclerosis: A consensus statement. Brain2024; 147(9): 2913–2933.
2.
MaggiPSatiPNairG, et al. Paramagnetic rim lesions are specific to multiple sclerosis: An international multicenter 3T MRI study. Ann Neurol2020; 88(5): 1034–1042.
3.
MeatonIAltokhisAAllenCM, et al. Paramagnetic rims are a promising diagnostic imaging biomarker in multiple sclerosis. Mult Scler2022; 28(14): 2212–2220.
4.
ClarkeMAParetoDPessini-FerreiraL, et al. Value of 3T susceptibility-weighted imaging in the diagnosis of multiple sclerosis. AJNR Am J Neuroradiol2020; 41(6): 1001–1008.
5.
MontalbanX. Revised McDonald criteria 2023. In: 40th congress of the European committee for treatment and research in multiple sclerosis (ECTRIMS), Copenhagen, 18–20 September 2024.
6.
AbsintaMSatiPMasuzzoF, et al. Association of chronic active multiple sclerosis lesions with disability in vivo. JAMA Neurol2019; 76(12): 1474.
7.
CagolABenkertPMelie-GarciaL, et al. Association of spinal cord atrophy and brain paramagnetic rim lesions with progression independent of relapse activity in people with MS. Neurology2024; 102(1): e207768.
8.
SaccoSVirupakshaiahAPapinuttoN, et al. Susceptibility-based imaging aids accurate distinction of pediatric-onset MS from myelin oligodendrocyte glycoprotein antibody-associated disease. Mult Scler2023; 29(14): 1736–1747.
9.
LiuXWangYWeiN, et al. The characteristics and influencing factors of paramagnetic rim lesions in Chinese MS patients: A 7T MRI study. Mult Scler2025; 31(8): 965–975.
10.
MartireMSMoiolaLMaggiP, et al. Reliability of paramagnetic rim lesion detection at 1.5T MRI in multiple sclerosis patients. Mult Scler2025; 31(8): 956–964.
